skip to Main Content

Dr. Ferraro on the Use of Molecular Profiling in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Pablo Ferraro, MD, medical oncologist, Memorial Healthcare System, discusses the use of molecular profiling in pancreatic cancer.

With molecular profiling, researchers may be able to identify potential actionable targets that could lead to additional treatment strategies in pancreatic cancer, explains Ferraro. A number of preclinical and phase I studies are being done, and further research could lead to larger phase II/III studies. Watch here. . .


Back To Top